Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
Investment analysts at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the ...
It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria ... and SYFOVRE for treating geographic atrophy ...